PHAT
PHAT
US71722W1071
Phathom Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
586.53M EUR
868.76M EUR
882.6M EUR
1.18B EUR
Enterprise Value
946.37M EUR
853.39M EUR
868M EUR
1.27B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
6.74x
--
--
--
Price to Sales
2.45x
3.62x
4.31x
8.08x
Price to Book
--
--
--
--
EV/Revenue
3.95x
3.56x
4.24x
8.64x
EV/EBITDA
-23.58x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-5.56%
-4.25%
-11.08%
-6.93%
ende